Global Information
회사소개 | 문의 | 비교리스트

세계의 임상 종양 차세대 시퀀싱 시장 : COVID 19에 의한 성장과 변화

Clinical Oncology Next Generation Sequencing Global Market Report 2020-30: COVID 19 Growth and Change

리서치사 The Business Research Company
발행일 2020년 11월 상품 코드 968171
페이지 정보 영문 200 Pages
가격
US $ 4,000 ₩ 4,470,000 PDF (Single User License)
US $ 6,000 ₩ 6,706,000 PDF (Site License)
US $ 8,000 ₩ 8,941,000 PDF (Enterprise License)


세계의 임상 종양 차세대 시퀀싱 시장 : COVID 19에 의한 성장과 변화 Clinical Oncology Next Generation Sequencing Global Market Report 2020-30: COVID 19 Growth and Change
발행일 : 2020년 11월 페이지 정보 : 영문 200 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 임상 종양 차세대 시퀀싱(Clinical Oncology Next Generation Sequencing) 시장을 조사했으며, 시장 특성, 시장 규모와 성장성, 기술별, 용도별, 최종사용자별, 지역별, 국가별 분석, 경쟁 상황, 기업 개요, 합병과 인수 동향, 시장 동향과 전략 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 시장 특성

제3장 시장 규모와 성장성

  • 시장 실적
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 시장 예측
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제4장 시장 세분화

  • 기술별 실적과 예측
    • 이온 반도체 시퀀싱
    • 파이로 시퀀싱
    • 합성 시퀀싱
    • 실시간 시퀀싱
    • 결찰 시퀀싱
    • Reversible Dye Termination 시퀀싱
    • 나노포어 시퀀싱
  • 용도별 실적과 예측
    • 스크리닝
    • 동반진단
    • 기타 진단
  • 최종사용자별 실적과 예측
    • 병원내 검사실
    • 임상 검사 조직
    • 진단 검사실

제5장 지역별, 국가별 분석

  • 지역별 실적과 예측
  • 국가별 실적과 예측

제6장 아시아태평양 시장

  • 시장 개요
  • 기술별 실적과 예측
  • 최종사용자별 실적과 예측

제7장 중국 시장

제8장 인도 시장

제9장 일본 시장

제10장 호주 시장

제11장 인도네시아 시장

제12장 한국 시장

제13장 서유럽 시장

제14장 영국 시장

제15장 독일 시장

제16장 프랑스 시장

제17장 동유럽 시장

제18장 러시아 시장

제19장 북미 시장

제20장 미국 시장

제21장 남미 시장

제22장 브라질 시장

제23장 중동 시장

제24장 아프리카 시장

제25장 경쟁 상황과 기업 개요

  • 경쟁 상황
  • 기업 개요
    • Thermo Fisher Scientific(Qiagen)
    • Oxford Nanopore Technologies
    • QIAGEN
    • Myriad Genetics
    • Illumina

제26장 주요 합병과 인수

제27장 시장 동향과 전략

제28장 시장 향후 전망과 성장성 분석

제29장 부록

KSM 20.11.17

Clinical Oncology Next Generation Sequencing Market Global Report 2020-30: Covid 19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global clinical oncology next generation sequencing market.

This report focuses on clinical oncology next generation sequencing market which is experiencing strong growth. The report gives a guide to the clinical oncology next generation sequencing market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the clinical oncology next generation sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Clinical Oncology Next Generation Sequencing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider clinical oncology next generation sequencing market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The clinical oncology next generation sequencing market section of the report gives context. It compares the clinical oncology next generation sequencing market with other segments of the clinical oncology next generation sequencing market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, clinical oncology next generation sequencing indicators comparison.

Scope

Markets Covered:

  • 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
  • 2) By Application: Screening; Companion Diagnostics; Other Diagnostics
  • 3) By End User: Hospital Laboratories; Clinical Research Oraganizations; Diagnostic laboratories
  • Companies Mentioned: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Clinical Oncology Next Generation Sequencing Market Characteristics

3. Clinical Oncology Next Generation Sequencing Market Size And Growth

  • 3.1. Global Clinical Oncology Next Generation Sequencing Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Clinical Oncology Next Generation Sequencing Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Clinical Oncology Next Generation Sequencing Market Segmentation

  • 4.1. Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Ion Semiconductor Sequencing
  • Pyro-Sequencing
  • Synthesis Sequencing
  • Real Time Sequencing
  • Ligation Sequencing
  • Reversible Dye Termination Sequencing
  • Nano-Pore Sequencing
  • 4.2. Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Screening
  • Companion Diagnostics
  • Other Diagnostics
  • 4.3. Global Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Laboratories
  • Clinical Research Oraganizations
  • Diagnostic laboratories

5. Clinical Oncology Next Generation Sequencing Market Regional And Country Analysis

  • 5.1. Global Clinical Oncology Next Generation Sequencing Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Clinical Oncology Next Generation Sequencing Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Clinical Oncology Next Generation Sequencing Market

  • 6.1. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Overview
  • 6.2. Asia-Pacific Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Clinical Oncology Next Generation Sequencing Market

  • 7.1. China Clinical Oncology Next Generation Sequencing Market Overview
  • 7.2. China Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Clinical Oncology Next Generation Sequencing Market

  • 8.1. India Clinical Oncology Next Generation Sequencing Market Overview
  • 8.2. India Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Clinical Oncology Next Generation Sequencing Market

  • 9.1. Japan Clinical Oncology Next Generation Sequencing Market Overview
  • 9.2. Japan Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Clinical Oncology Next Generation Sequencing Market

  • 10.1. Australia Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Clinical Oncology Next Generation Sequencing Market

  • 11.1. Indonesia Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Clinical Oncology Next Generation Sequencing Market

  • 12.1. South Korea Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Clinical Oncology Next Generation Sequencing Market

  • 13.1. Western Europe Clinical Oncology Next Generation Sequencing Market Overview
  • 13.2. Western Europe Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Clinical Oncology Next Generation Sequencing Market

  • 14.1. UK Clinical Oncology Next Generation Sequencing Market Overview
  • 14.2. UK Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Clinical Oncology Next Generation Sequencing Market

  • 15.1. Germany Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Clinical Oncology Next Generation Sequencing Market

  • 16.4. France Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Clinical Oncology Next Generation Sequencing Market

  • 17.1. Eastern Europe Clinical Oncology Next Generation Sequencing Market Overview
  • 17.2. Eastern Europe Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Clinical Oncology Next Generation Sequencing Market

  • 18.1. Russia Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Clinical Oncology Next Generation Sequencing Market

  • 19.1. North America Clinical Oncology Next Generation Sequencing Market Overview
  • 19.2. North America Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Clinical Oncology Next Generation Sequencing Market

  • 20.1. USA Clinical Oncology Next Generation Sequencing Market Overview
  • 20.2. USA Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Clinical Oncology Next Generation Sequencing Market

  • 21.1. South America Clinical Oncology Next Generation Sequencing Market Overview
  • 21.2. South America Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Clinical Oncology Next Generation Sequencing Market

  • 22.1. Brazil Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Clinical Oncology Next Generation Sequencing Market

  • 23.1. Middle East Clinical Oncology Next Generation Sequencing Market Overview
  • 23.2. Middle East Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Clinical Oncology Next Generation Sequencing Market

  • 24.1. Africa Clinical Oncology Next Generation Sequencing Market Overview
  • 24.2. Africa Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Clinical Oncology Next Generation Sequencing Market Competitive Landscape And Company Profiles

  • 25.1. Clinical Oncology Next Generation Sequencing Market Competitive Landscape
  • 25.2. Clinical Oncology Next Generation Sequencing Market Company Profiles
    • 25.2.1. Thermo Fisher Scientific(Qiagen)
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Oxford Nanopore Technologies
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. QIAGEN
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Myriad Genetics
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Illumina
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Clinical Oncology Next Generation Sequencing Market

27. Clinical Oncology Next Generation Sequencing Market Trends And Strategies

28. Clinical Oncology Next Generation Sequencing Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q